Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Rag. You need specific rx coverage, not just basic medical coverage to pay for prescriptions. You have missed the primary point re. V. The point was how to optimize value for shareholders. The public health option may offer the best deal for shareholders and the American public
Did I read cantor wrong? Earnings to go to .25 instead of .18 and this is a decrease???
Any estimates when top line results will be announced?
BB you may be on to something. Plantiff may represent a competitive interest or trying pose strawman obstacles to lower buyout price
Lawsuit serves 2 purposes. It provides someone who is long with cover just in case something goes wrong with timely fda approval and secondly it helps someone who is a substantial short, trying to hold the stock price in place while they try to cover.
Dud thanx. I got 10k of those 40,000
Zip. The other purposes are to act as"golden handcuffs" inventing key people to stay and also to reward people for past and future performance
Ffrol. Why would they need to do a Ph. 1 at all? They ran about 11 cohorts the first time.
Nas. The expertise and professionalism of this board is way beyond your pay grade. You'll need stronger info to make legitimate claims
20k calls! Big event or max pain?
BB could blackrock be taking such a large position to influence some settlement between Amrn and supplement industry?
1. I thought I was watching a new vacepa commercial until they said Repatha
2. Unless they want a large law suit the management team would not dare to delay a bo. They would be taken care of in the negotiation details.
I believe NAjariams dad is an M.D. don't know his specialty.
Is IPIX following all of the patients from the various cohorts of K?
Are they allowed to publish the most recent P1 follow up data on these patients?
AVII I've only had 2-3 stat classes and sometimes have trouble following all of your analysis.(which I respect greatly). If I understood your last post NWBO results will be similar to current standard of care. OK but not outstanding. Q. Will such a result be enough for approval? Q. Someone posted Gotlieb statements that FDA will consider drugs where P value does not initially appear strong, but where there seems to be survival benefit.
Based on survival results and FDA position, does nwbo drug have a good chance of approval?
For a long time I have been wondering if the Chinese government is behind much of the Lynas criticism. LYS is the only real competitor to China and they would love to have a monopoly. I'm surprised someone has not recognized this situation. I'm also surprised some large firm with Malaysian influence has not tried to buyout Lys. This has enormous potential and is a national security interest for several countries. Any comments
There is a post on NWBO board "smithonstocks". If you substitute IPIX for NWBO while reading the portion about shorting the stock, it is startling. I have been trying to figure out why the shorts are still here. This article notes that shares are naked shorts and if the company can be forced into Bankruptcy, no one will ever have to answer for illegal actions. The article is worth a read.
Are Kennedy, Ketchum, kalb and j.t. based in. U.S?
Think about it. You're the biotech exec who has had great results, you just raised 2p0 million, you pocketed 10 million personally, you will be exec of the year. You're fat and happy and it's year end. If it's not very, very important I'm not flying 6 hours the week before Christmas to say hello to my bankers.
There are only 2 ways such a meeting is scheduled. Either Amrn has asked them to explore m&a deals or a suitor has expressed interest thru Jefferies. This is not idle chatter
AVII can you comment on By post 839. Is this a fail safe for the company /results?
BB after AHA I suggested avoiding fad. Your reply was that fad new label was needed for insurance coverage to reach potential sales targets???
What is Leo's email address. I think we should all ask him for a definitive FDA meeting date. He does owe us that much. I am very long and will be as long as necessary.
I nominate DUD for Man of the Year. He is the hardest working, most selfless, and tirelessly looking out for his fellow man. He does this 24 hours a day with a pure heart and is motivated only by the joy of helping IPIX investors. He holds the record for the most posts guiding us on how to best profit from his sage advice. IF YOU BELIEVE ANY OF HIS OR HIS MINIONS BS, I HAVE SOME SWAMP LAND FOR SALE>
The only issue is results by asco. They have plenty of funds to get them thru til then. If positive they will issue a secondary (as all biotechs do) soon after announcement , if negative you just lost your 30 cent option.
Smith analysis very impressive. A MUST READ if you are invested in nwbo
AF is most likely throwing up a smoke screen. He will try every trick in the book to Rob stock holders and favor manipulators. Be wary.
AVII. Based on your comments do I gather that you were not impressed with interim data and are not positive on nmbo??
Gentlemen. What we have here is a 30 cent call option which expires in June, asco. We can debate all we want, but the data analysis is the only thing that will give us our answers. Any delay beyond Pasco will result in our stock being virtually worthless. Strong data will make us smart inciteful investors. Got a longs
Shar. Thanks for confirmation. This should put a floor under the stock
Tia where is this documented by fad. Would like to see exact wording
Has it been confirmed that secondary is pre-bought? Final price?
Has it been confirmed that secondary is pre-bought? Final price?
Secondary is standard operating procedure. It secures company financial position and gives institutions there last chance to get in at a reasonable price. If it is absorbed quickly you won't even notice this blip
That may be the hidden message behind Fridays announcement. Whether new incentive shares have been earned is up for debate. The urgency to get this done now is a clear signal that current management does not want to miss out on a highly probable opportunity. I've seen this many times in my 30 years as a compensation consultant. Keep your fingers crossed they are right and have more info than we do
Pyr If I understand your argument, based on your most realistic case V would be stat sig and should be a block buster .
Herper tweet may be correct. V sales will cost/reach $9B. and will save the health care system 5x-10x that initial cost.
BB I previously posted about the stock sales by executives. Poorly timed and executed, and fueled the shorts run. Management has taken the ball this far , but is ill equipped to effectively grow a worldwide organization. They should be talking to BP and/or hiring a firm to pursue strategic options.
I should have said, Why was there little stock price reaction to the interim report?
Why was there little reaction to interim data???